Clinical Trial

Evaluation of Postoperative Outcomes and Mortality in Laparoscopic and Robotic Distal Pancreatectomy

Study acronym: PREINSTRUCT
Completed
View on ClinicalTrials.gov →
Summary
Minimally invasive distal pancreatectomy can be performed using either a laparoscopic or robotic approach. These minimally invasive techniques are becoming increasingly common in the surgical treatment of both benign and malignant pancreatic lesions. They offer several advantages over traditional open surgery, such as less postoperative pain, better cosmetic results, faster recovery, less blood loss during surgery, and lower healthcare costs. However, despite these advantages, evidence comparing postoperative outcomes, particularly complications, between laparoscopic and robotic distal pancreatectomy remains limited. Previous studies suggest that robotic surgery may offer technical benefits, such as greater accuracy and precision, which could potentially result in fewer complications. However, the available literature is diverse and often based on small cohorts.
Trial Details
NCT Number NCT07338409
Lead Sponsor Jessa Hospital
Conditions Distal Pancreatectomy (DP)
Enrollment 126 participants
Start Date 2025-03-04
Primary Completion 2025-06-05 (estimated)
Study Completion 2025-06-05 (estimated)
Updated on ClinicalTrials.gov 2026-01-13